The 6^th CDD for biologics is pivotal as biopharmaceutical companies include a larger degree of computation in their design and look to this for cost-efficiency and accelerating drug discovery. With a focus on real life approaches to using computational programming and delving into the biologics and drug development, this is an essential meeting to advance your work.

This is the only meeting to leverage advanced programs to better understand your candidate, with case studies demonstrating how to enhance developability of biologic candidates into clinic, and engineer novel molecules with therapeutic potential.